Figure 8From: Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s DiseasePatients with Perineal Disease who completed 12 weeks of treatment showing change in Perineal Disease Activity Index during this period. Note Patient 2 had a flare of Crohn’s unrelated to treatment; Patient 10 flared after stopping treatment.Back to article page